|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:ARMCX4-BTK (FusionGDB2 ID:6794) |
Fusion Gene Summary for ARMCX4-BTK |
Fusion gene summary |
Fusion gene information | Fusion gene name: ARMCX4-BTK | Fusion gene ID: 6794 | Hgene | Tgene | Gene symbol | ARMCX4 | BTK | Gene ID | 100131755 | 695 |
Gene name | armadillo repeat containing X-linked 4 | Bruton tyrosine kinase | |
Synonyms | CXorf35|GASP4 | AGMX1|AT|ATK|BPK|IGHD3|IMD1|PSCTK1|XLA | |
Cytomap | Xq22.1 | Xq22.1 | |
Type of gene | protein-coding | protein-coding | |
Description | armadillo repeat-containing X-linked protein 4armadillo repeat containing, X-linked 4 pseudogene | tyrosine-protein kinase BTKB-cell progenitor kinaseBruton agammaglobulinemia tyrosine kinaseBruton's tyrosine kinaseagammaglobulinaemia tyrosine kinasedominant-negative kinase-deficient Brutons tyrosine kinasetruncated Bruton agammaglobulinemia tyro | |
Modification date | 20200313 | 20200329 | |
UniProtAcc | . | Q06187 | |
Ensembl transtripts involved in fusion gene | ENST00000431677, ENST00000423738, | ENST00000372880, ENST00000308731, ENST00000464567, | |
Fusion gene scores | * DoF score | 3 X 3 X 3=27 | 2 X 2 X 2=8 |
# samples | 3 | 2 | |
** MAII score | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(2/8*10)=1.32192809488736 | |
Context | PubMed: ARMCX4 [Title/Abstract] AND BTK [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ARMCX4(100673988)-BTK(100626689), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | BTK | GO:0018108 | peptidyl-tyrosine phosphorylation | 11606584 |
Fusion gene breakpoints across ARMCX4 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across BTK (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LIHC | TCGA-DD-AAEH-01A | ARMCX4 | chrX | 100673988 | + | BTK | chrX | 100626689 | - |
Top |
Fusion Gene ORF analysis for ARMCX4-BTK |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-3CDS | ENST00000431677 | ENST00000372880 | ARMCX4 | chrX | 100673988 | + | BTK | chrX | 100626689 | - |
3UTR-3CDS | ENST00000431677 | ENST00000308731 | ARMCX4 | chrX | 100673988 | + | BTK | chrX | 100626689 | - |
3UTR-intron | ENST00000431677 | ENST00000464567 | ARMCX4 | chrX | 100673988 | + | BTK | chrX | 100626689 | - |
intron-3CDS | ENST00000423738 | ENST00000372880 | ARMCX4 | chrX | 100673988 | + | BTK | chrX | 100626689 | - |
intron-3CDS | ENST00000423738 | ENST00000308731 | ARMCX4 | chrX | 100673988 | + | BTK | chrX | 100626689 | - |
intron-intron | ENST00000423738 | ENST00000464567 | ARMCX4 | chrX | 100673988 | + | BTK | chrX | 100626689 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for ARMCX4-BTK |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for ARMCX4-BTK |
Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | BTK |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Non-receptor tyrosine kinase indispensable for B lymphocyte development, differentiation and signaling. Binding of antigen to the B-cell antigen receptor (BCR) triggers signaling that ultimately leads to B-cell activation. After BCR engagement and activation at the plasma membrane, phosphorylates PLCG2 at several sites, igniting the downstream signaling pathway through calcium mobilization, followed by activation of the protein kinase C (PKC) family members. PLCG2 phosphorylation is performed in close cooperation with the adapter protein B-cell linker protein BLNK. BTK acts as a platform to bring together a diverse array of signaling proteins and is implicated in cytokine receptor signaling pathways. Plays an important role in the function of immune cells of innate as well as adaptive immunity, as a component of the Toll-like receptors (TLR) pathway. The TLR pathway acts as a primary surveillance system for the detection of pathogens and are crucial to the activation of host defense. Especially, is a critical molecule in regulating TLR9 activation in splenic B-cells. Within the TLR pathway, induces tyrosine phosphorylation of TIRAP which leads to TIRAP degradation. BTK plays also a critical role in transcription regulation. Induces the activity of NF-kappa-B, which is involved in regulating the expression of hundreds of genes. BTK is involved on the signaling pathway linking TLR8 and TLR9 to NF-kappa-B. Transiently phosphorylates transcription factor GTF2I on tyrosine residues in response to BCR. GTF2I then translocates to the nucleus to bind regulatory enhancer elements to modulate gene expression. ARID3A and NFAT are other transcriptional target of BTK. BTK is required for the formation of functional ARID3A DNA-binding complexes. There is however no evidence that BTK itself binds directly to DNA. BTK has a dual role in the regulation of apoptosis. {ECO:0000269|PubMed:11606584, ECO:0000269|PubMed:16415872, ECO:0000269|PubMed:16517732, ECO:0000269|PubMed:16738337, ECO:0000269|PubMed:17932028, ECO:0000269|PubMed:9012831}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for ARMCX4-BTK |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for ARMCX4-BTK |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ARMCX4-BTK |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | BTK | Q06187 | DB09053 | Ibrutinib | Inhibitor | Small molecule | Approved |
Tgene | BTK | Q06187 | DB09053 | Ibrutinib | Inhibitor | Small molecule | Approved |
Tgene | BTK | Q06187 | DB09053 | Ibrutinib | Inhibitor | Small molecule | Approved |
Tgene | BTK | Q06187 | DB09053 | Ibrutinib | Inhibitor | Small molecule | Approved |
Tgene | BTK | Q06187 | DB01254 | Dasatinib | Small molecule | Approved|Investigational | |
Tgene | BTK | Q06187 | DB01254 | Dasatinib | Small molecule | Approved|Investigational | |
Tgene | BTK | Q06187 | DB01254 | Dasatinib | Small molecule | Approved|Investigational | |
Tgene | BTK | Q06187 | DB01254 | Dasatinib | Small molecule | Approved|Investigational | |
Tgene | BTK | Q06187 | DB11703 | Acalabrutinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | BTK | Q06187 | DB11703 | Acalabrutinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | BTK | Q06187 | DB11703 | Acalabrutinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | BTK | Q06187 | DB11703 | Acalabrutinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | BTK | Q06187 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | BTK | Q06187 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | BTK | Q06187 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | BTK | Q06187 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | BTK | Q06187 | DB15035 | Zanubrutinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | BTK | Q06187 | DB15035 | Zanubrutinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | BTK | Q06187 | DB15035 | Zanubrutinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | BTK | Q06187 | DB15035 | Zanubrutinib | Inhibitor | Small molecule | Approved|Investigational |
Top |
Related Diseases for ARMCX4-BTK |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | BTK | C0221026 | X-linked agammaglobulinemia | 27 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | BTK | C0472813 | X-linked agammaglobulinemia with growth hormone deficiency | 4 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Tgene | BTK | C0001768 | Agammaglobulinemia | 1 | CTD_human |
Tgene | BTK | C0086438 | Hypogammaglobulinemia | 1 | CTD_human |